UK SACT Board (Formally UK Chemotherapy Board)

The UK SACT (Systemic Anti-Cancer Therapy) Board provides guidance, oversight and support for the continuing development of SACT services in the UK.

Netty Cracknell is an experienced consultant oncology pharmacist with over 22 years of practice across NHS and independent healthcare organisations in the UK. She is the Principal Pharmacist for Cancer Services at Lewisham and Greenwich NHS Trust and also holds a clinical leadership role supporting cancer pharmacy services within an NHS Integrated Care Board.

Netty is the Past President of the International Society of Oncology Pharmacy Practitioners (ISOPP) and previously served as Co-Chair of the UK Systemic Anti-Cancer Therapy (SACT) Board. She has held several national leadership positions within the British Oncology Pharmacy Association (BOPA) and has led numerous UK and international initiatives to advance oncology pharmacy practice and patient safety.

She is a Fellow of the Royal College of Pharmacy (FRCPharm) and a Fellow of the British Oncology Pharmacy Association (fBOPA). Her professional interests include digital innovation, medicines safety, workforce development, and improving the quality and accessibility of cancer services. She is particularly passionate about education and training, supporting the development of the pharmacy workforce and expanding equitable access to learning opportunities for professionals across the UK and internationally.

Joseph is the Education and Training Lead, Non‑Medical Prescribing (NMP) Pharmacy Lead, and a Specialist Cancer Pharmacist at The Christie NHS Foundation Trust, with advanced clinical and research expertise in colorectal cancer and care closer to home models. An independent prescriber within the colorectal cancer specialty, he leads patient‑facing services and drives applied health research to improve clinical outcomes and service delivery.

In his education leadership role, Joseph provides strategic oversight and direction for pharmacy education and training across the organisation, leading the development and delivery of education and training strategy, workforce development initiatives, and advancing practice pathways aligned to service need and national priorities. As NMP Pharmacy Lead, he provides professional leadership for independent prescribing, supporting governance, education, and the expansion of prescribing practice across pharmacy services. Joseph is also an Honorary Clinical Lecturer in the Division of Pharmacy & Optometry at the University of Manchester, where he teaches across undergraduate and postgraduate cancer programmes.

His national and international leadership includes serving as Chair of the British Oncology Pharmacy Association (BOPA) from 2022 to 2025, election to the UK SACT Board (2023 to 2026 - including Co‑Chair in 2025), and election as Vice Chair of the International Society of Oncology Pharmacy Practitioners (ISOPP) Education Committee from 2025. He also was also part of the UK Pharmacy Professional Leadership Advisory Board (UKPPL) from 2023 to 2026, marking a key step in his national professional leadership journey and subsequently leading to his election to the Royal College of Pharmacy’s (RCPharm) English Pharmacy Advisory Council (EPAC) in April 2026, where he contributes to strategic advice on pharmacy practice and policy across England. Joseph is also a Fellow of the Royal College of Pharmacy (RCPharm). He is deeply committed to advancing excellence in pharmacy through education, research, leadership, and innovation.